<DOC>
	<DOCNO>NCT02038023</DOCNO>
	<brief_summary>To determine percentage woman achieve anemia correction single dose 1000mg low molecular weight iron dextran ( infed ) .</brief_summary>
	<brief_title>Intravaneous Iron ( 1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes ) Pregnant Women</brief_title>
	<detailed_description>To determine percentage woman achieve anemia correction single dose 1000mg low molecular weight iron dextran ( infed ) . To determine whether IV iron supplementation high satisfaction treatment compare oral supplementation population previously intolerant unresponsive oral iron . To evaluate safety IV low molecular weight iron dextran pregnant woman . To assess maternal fetal outcomes-preterm delivery , low birth weight delivery , ER visit hospitalization related preterm labor , preterm contraction , ante-partum post-partum transfusion , maternal hemoglobin post-partum visit IV iron supplementation group .</detailed_description>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Iron-Dextran Complex</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>pregnant woman intolerable oral iron . hbg &lt; 10.9 g/dl second third trimester . know sensitivity IV iron . hemoglobinopathy . hemolytic anemia . woman receive receive blood transfusion . woman significant vaginal bleeding ( &gt; 200 cc blood loss ) prior delivery . woman document history allergy one class drug clinically significant anemia require therapy opinion obstetrician , first trimester .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Iv iron pregnant woman</keyword>
	<keyword>second third trimester</keyword>
</DOC>